Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$940K Sell
39,040
-363
-0.9% -$9.5K 0.05% 223
2026
Q1
$1.11M Sell
39,403
-1,107
-3% -$29.5K 0.06% 209
2025
Q4
$1.01M Sell
40,510
-2,389
-6% -$60.2K 0.06% 213
2025
Q3
$1.09M Sell
42,899
-346
-0.8% -$8.54K 0.06% 206
2025
Q2
$1.05M Sell
43,245
-9,788
-18% -$228K 0.06% 204
2025
Q1
$1.34M Buy
53,033
+1,666
+3% +$43.6K 0.09% 185
2024
Q4
$1.36M Sell
51,367
-8,251
-14% -$224K 0.09% 175
2024
Q3
$1.73M Sell
59,618
-1,264
-2% -$36.9K 0.12% 152
2024
Q2
$1.7M Sell
60,882
-3,092
-5% -$85.1K 0.14% 126
2024
Q1
$1.78M Sell
63,974
-58,150
-48% -$1.61M 0.13% 137
2023
Q4
$3.52M Sell
122,124
-4,241
-3% -$128K 0.27% 82
2023
Q3
$4.19M Sell
126,365
-1,525
-1% -$53.9K 0.35% 66
2023
Q2
$4.69M Buy
127,890
+9,941
+8% +$387K 0.37% 63
2023
Q1
$4.81M Sell
117,949
-5,201
-4% -$225K 0.53% 46
2022
Q4
$6.31M Sell
123,150
-2,598
-2% -$125K 0.73% 36
2022
Q3
$5.5M Sell
125,748
-783
-0.6% -$38K 0.68% 42
2022
Q2
$6.63M Buy
126,531
+1,756
+1% +$89.5K 0.78% 31
2022
Q1
$6.46M Sell
124,775
-4,942
-4% -$256K 0.65% 38
2021
Q4
$7.66M Sell
129,717
-4,652
-3% -$230K 0.71% 34
2021
Q3
$5.78M Sell
134,369
-876
-0.6% -$38.8K 0.55% 42
2021
Q2
$5.3M Sell
135,245
-4,198
-3% -$163K 0.5% 43
2021
Q1
$5.05M Buy
139,443
+13,082
+10% +$464K 0.51% 43
2020
Q4
$4.65M Sell
126,361
-5,495
-4% -$202K 0.5% 41
2020
Q3
$4.55M Sell
131,856
-3,107
-2% -$109K 0.55% 39
2020
Q2
$4.42M Buy
134,963
+6,231
+5% +$212K 0.57% 39
2020
Q1
$4.35M Sell
128,732
-18,193
-12% -$620K 0.65% 34
2019
Q4
$5.42M Sell
146,925
-4,592
-3% -$164K 0.64% 37
2019
Q3
$5.1M Buy
151,517
+3,237
+2% +$118K 0.66% 37
2019
Q2
$6.09M Sell
148,280
-7,962
-5% -$316K 0.78% 33
2019
Q1
$6.3M Sell
156,242
-1,651
-1% -$66.1K 0.82% 33
2018
Q4
$6.54M Sell
157,893
-5,891
-4% -$245K 0.96% 30
2018
Q3
$6.85M Sell
163,784
-3,778
-2% -$145K 0.84% 31
2018
Q2
$5.77M Sell
167,562
-1,027
-0.6% -$35.1K 0.74% 33
2018
Q1
$5.68M Sell
168,589
-827
-0.5% -$28.4K 0.75% 31
2017
Q4
$5.82M Sell
169,416
-5,500
-3% -$188K 0.75% 33
2017
Q3
$5.92M Buy
174,916
+107,063
+158% +$3.44M 0.83% 32
2017
Q2
$2.16M Buy
67,853
+1,175
+2% +$37.1K 0.37% 60
2017
Q1
$2.16M Sell
66,678
-14
-0% -$441 0.38% 60
2016
Q4
$2.06M Sell
66,692
-2,387
-3% -$72.9K 0.39% 58
2016
Q3
$2.22M Sell
69,079
-268
-0.4% -$8.96K 0.44% 53
2016
Q2
$2.32M Sell
69,347
-2,219
-3% -$70.8K 0.46% 53
2016
Q1
$2.01M Sell
71,566
-684
-0.9% -$19.5K 0.42% 57
2015
Q4
$2.21M Buy
72,250
+37
+0.1% +$1.16K 0.48% 55
2015
Q3
$2.15M Buy
72,213
+7,047
+11% +$226K 0.47% 56
2015
Q2
$2.07M Sell
65,166
-11,159
-15% -$364K 0.42% 59
2015
Q1
$2.52M Sell
76,325
-932
-1% -$29.6K 0.5% 54
2014
Q4
$2.28M Sell
77,257
-1,001
-1% -$28.7K 0.46% 55
2014
Q3
$2.2M Sell
78,258
-1,722
-2% -$48.3K 0.44% 57
2014
Q2
$2.25M Sell
79,980
-1,349
-2% -$38.5K 0.45% 58
2014
Q1
$2.48M Buy
81,329
+2,206
+3% +$65.8K 0.51% 51
2013
Q4
$2.3M Sell
79,123
-11,114
-12% -$323K 0.49% 52
2013
Q3
$2.46M Sell
90,237
-5,151
-5% -$140K 0.56% 43
2013
Q2
$2.54M Buy
+95,388
New +$2.64M 0.63% 41

Other funds holding PFE

Courier Capital's PFE Position: Q2 2026 in Review

Courier Capital reduced its Pfizer (PFE) stake by 0.92% in Q2 2026, selling an estimated $9.5K and leaving 39,040 shares worth $940K. The position accounts for 0.05% of the portfolio, ranked #223.

Courier Capital first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.66M in Q4 2021. 1,306 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Courier Capital held 39,040 shares of Pfizer worth $940K as of Q2 2026.
  • Courier Capital sold 363 Pfizer shares in Q2 2026, an estimated $9.5K.
  • Pfizer made up 0.05% of Courier Capital's portfolio in Q2 2026, its #223 holding.
  • Courier Capital first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Courier Capital's Pfizer position peaked at $7.66M in Q4 2021.
  • 1,306 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.